Endo Pays $39M To End Whistleblower's Fluoride Tablet Suit
An Endo Health Solutions-owned generic-drug maker will pay $39 million to the federal government and 47 states to settle a whistleblower's New York federal suit alleging it sold multivitamin tablets with...To view the full article, register now.
Already a subscriber? Click here to view full article